Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

94.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
94.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A uniform tissue-clearing framework and mesoSPIM-ultra enable cm-scale single-neuron tracing.

bioRxiv : the preprint server for biology·2026
Same author

Mesenchymal-derived neural progenitors underlie local <i>insulin</i> production and neuronal transdifferentiation during retina regeneration.

bioRxiv : the preprint server for biology·2026
Same author

Integration of a neuronal RNAseq dataset with the draft Gryllus bimaculatus transcriptome refines gene predictions and highlights potential systematic response to injury.

PloS one·2026
Same author

Two axolotl-adapted cell-ablation platforms reveal macrophage-dependent processes essential for spinal-cord and skeletal regeneration.

bioRxiv : the preprint server for biology·2026
Same author

Zebrafish genetic model of neuromuscular degeneration associated with Atrogin-1 expression.

PLoS genetics·2026
Same author

Sodium-glucose co-transporter 2 inhibition improves age-dependent kidney microvascular rarefaction.

Kidney international·2025

Related Experiment Video

Updated: Mar 21, 2026

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

6.1K

The small molecule ML233 is a direct inhibitor of tyrosinase function.

Romain Menard1, Aissette Baanannou1, Caroline Halluin1

  • 1MDI Biological Laboratory, Kathryn W. Davis Center for Regenerative Biology and Aging, Bar Harbor, ME, USA.

Communications Biology
|March 29, 2025
PubMed
Summary

Researchers identified ML233 as a potent tyrosinase inhibitor that reduces melanin production in skin cells. This compound shows promise for treating skin conditions associated with melanogenesis with minimal side effects.

More Related Videos

Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

12.1K
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.9K

Related Experiment Videos

Last Updated: Mar 21, 2026

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

6.1K
Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

12.1K
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.9K

Area of Science:

  • Biochemistry
  • Dermatology
  • Pharmacology

Background:

  • Melanogenesis, the synthesis of melanin, is crucial for skin pigmentation.
  • Dysregulation of melanogenesis causes various skin disorders like albinism and vitiligo.
  • Tyrosinase is the key enzyme in melanogenesis, making it a target for therapeutic intervention.

Purpose of the Study:

  • To characterize ML233 as a potent inhibitor of tyrosinase activity.
  • To evaluate the efficacy and safety of ML233 in reducing melanin production.
  • To explore ML233's potential therapeutic applications for skin diseases.

Main Methods:

  • In vitro and in vivo assays were used to assess tyrosinase inhibition.
  • Zebrafish models and murine melanoma cells were employed to study ML233's effects.
  • Molecular docking was predicted to understand the interaction between ML233 and tyrosinase.

Main Results:

  • ML233 demonstrated potent inhibition of tyrosinase activity.
  • Reduced melanin production was observed in zebrafish and murine melanoma cells.
  • ML233 exhibited no significant toxic side effects in the tested models.
  • Direct interaction between ML233 and tyrosinase was predicted.

Conclusions:

  • ML233 is a safe and effective inhibitor of melanogenesis.
  • ML233 holds potential for treating skin diseases linked to melanin production.
  • Targeting tyrosinase with ML233 offers a promising therapeutic strategy.